The energetis of ligand binding at catecholamine receptors

Trends in Pharmacological Sciences

Volumn 17, Issue 7, 1996, Pages 238-244

  Strange, Philip G ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; LIGAND;

BINDING AFFINITY; CATECHOLAMINE RELEASE; CONFORMATIONAL TRANSITION; DRUG DESIGN; DRUG RECEPTOR BINDING; ELECTROSTATIC PRECIPITATION; ENERGY TRANSFER; ENTHALPY; HYDROGEN BOND; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; CHEMISTRY; GENETICS; METABOLISM; MUTATION;

DRUG DESIGN; HYDROGEN BONDING; LIGANDS; MUTATION; RECEPTORS, CATECHOLAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 0030176923     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-6147(96)10025-0     Document Type: Review

References (51)

1. 1 Page, M. I. and Jencks, W. P. (1971) Proc. Natl. Acad. Sci. U. S. A. 68, 1678-1683
2. 2 Williams, D. H. et al. (1991) J. Am. Chem. Soc. 113, 7020-7030
3. 3 Searle, M. S. and Williams, D. H. (1992) J. Am. Chem. Soc. 114, 10690-10697
4. 4 Searle, M. S., Williams, D. H. and Gerhard, U. (1992) J. Am. Chem. Soc. 114, 10697-10704
5. 5 Woodward, R. et al. (1996) J. Neurochem. 66, 394-402
6. 6 Ross, E. M. (1989) Neuron 3, 141-152
7. 7 Henderson, R. et al. (1990) J. Mol. Biol. 213, 899-929
8. 8 Schertler, G. X., Villa, C. and Henderson, R. (1993) Nature 362, 770-772
9. 9 Baldwin, J. (1993) EMBO J. 12, 1693-1703
10. 10 Lie, J., Schoneberg, T., van Rhee, M. and Wess, J. (1995) J. Biol. Chem. 270, 19532-19539
11. 11 Donnelly, D., Findlay, J. B. C. and Blundell, T. L. (1994) Recept. Channels 2, 61-78
12. 12 Javitch, J. A., Fu, D., Chen, J. and Karlin, A. (1995) Neuron 14, 825-831
13. 13 Javitch, J. A., Fu, D. and Chen, J. (1995) Biochemistry 34, 16433-16439
14. 14 Wess, J. (1993) Trends Pharmacol. Sci. 14, 308-313
15. 15 El Tayar, N. et al. (1988) Eur. J. Med. Chem. 23, 173-182
16. 16 Wells, J. A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 1-6
17. 17 Miller, D. D. et al. (1988) Trends Pharmacol. Sci. 9, 282-284
18. 18 D'Souza, U. M. and Strange, P. G. (1995) Biochemistry 34, 13635-13641
19. 19 Dixon, R. A. F., Sigal, I. S. and Strader, C. D. (1988) Cold Spring Harbor Symp. Quant. Biol. 53, 487-497
20. 20 Williamson, R. A. and Strange, P. G. (1990) J. Neurochem. 55, 1357-1365
21. 21 Hollis, C. M. and Strange, P. G. (1992) Biochem. Pharmacol. 44, 325-334
22. 22 Mansour, A. et al. (1992). Eur. J. Pharmacol. 227, 205-214
23. 23 Fraser, C. M. et al. (1989) Mol. Pharmacol. 36, 840-847
24. 24 Page, K. M., Curtis, C. A. M., Jones, P. G. and Hulme, E. C. (1995) Eur. J. Pharmacol. 289, 429-437
25. 25 Wang, C., Gallaher, T. K. and Shih, J. C. (1993) Mol. Pharmacol. 43, 931-940
26. 26 Ho, B. Y. et al. (1992) FEBS Lett. 312, 259-262
27. 27 Galzi, J. L., Revah, F., Bessic, A. and Changeux, J. P. (1991) Annu. Rev. Pharmacol. Toxicol. 31, 37-72
28. 28 Ripoll, D. R. et al. (1993) Proc. Natl. Acad. Sci. U. S .A. 90, 5128-5132
29. 29 Radic, Z. et al. (1992) Biochemistry 31, 9760-9767
30. 30 Czajowski, C., Kaufman, C. and Karlin, A. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 6285-6289
31. 31 Seeman, P. (1980) Pharmacol. Rev. 32, 229-313
32. 32 Wang, C., Buck, M. A. and Fraser, C. M. (1991) Mol. Pharmacol. 40, 168-179
33. 33 Pollock, N. J. et al. (1992) J. Biol. Chem. 267, 17780-17786
34. 34 Cox, B. A. et al. (1992) J. Neurochem. 59, 627-635
35. 35 Strader, C. D. et al. (1989) J. Biol. Chem. 264, 13572-13578
36. 36 Fersht, A. R. et al. (1985) Nature 314, 235-238
37. 37 Street, I. P., Armstrong, C. R. and Withers, S. G. (1986) Biochemistry 25, 6021-6027
38. 38 Williams, D. H. et al. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 1172-1178
39. 39 Trump-Kallmeyer, S., Hoflack, J., Bruinvels, A. and Hibert, M. (1992) J. Med. Chem. 35, 3448-3462
40. 40 Hunter, C. A., Singh, J. and Thornton, J. M. (1991) J. Mol. Biol. 234, 837-846
41. 41 Serrano, L., Bycroft, M. and Fersht, A. R. (1991) J. Mol. Biol. 234, 465-475
42. 42 Warshel, A. and Levitt, M. (1976) J. Mol. Biol. 103, 227-249
43. 43 Choudhary, M. S., Craigo, S. and Roth, B. L. (1993) Mol. Pharmacol. 43, 755-761
44. 44 Choudhary, M. S. et al. (1995) Mol. Pharmacol. 47, 450-457
45. 45 Cho, W., Taylor, L. P., Mansour, A. and Akil, H. (1995) J. Neurochem. 65, 2105-2115
46. 46 Chothia, C. (1974) Nature 248, 338-339
47. 47 Shirley, B. A., Stanssens, P., Hahn, U. and Pace, C. N. (1992) Biochemistry 31, 725-732
48. 48 Privalov, P. L. and Makhatadze, G. I. (1993) J. Mol. Biol. 232, 660-679
49. 49 Serrano, L. et al. (1992) J. Mol. Biol. 224, 783-804
50. 50 Testa, B. et al. (1987) Biochem. Pharmacol. 36, 4041-4046
51. 51 Kilpatrick, G. J. et al. (1986) Mol. Pharmacol. 30, 226-234